MarketsLoading…
S&P 500—
NASDAQ 100—
Dow Jones—
Russell 2000—
Gold—
Crude Oil—
20Y Treasury—
US Dollar—
VIX—
Emerging Mkts—
Intl Developed—
Bitcoin—
S&P 500—
NASDAQ 100—
Dow Jones—
Russell 2000—
Gold—
Crude Oil—
20Y Treasury—
US Dollar—
VIX—
Emerging Mkts—
Intl Developed—
Bitcoin—

Industry Coverage

Sectors We Serve

Deep sector expertise across the industries where growth capital and strategic transactions matter most.

HealthcareTechnologyArtificial IntelligenceAgricultureAviationEnergyMiningReal EstateConsumer Packaged GoodsTelecommunicationsBiotechnologyDefense & Aerospace
MarketsLoading…
S&P 500—
NASDAQ 100—
Dow Jones—
Russell 2000—
Gold—
Crude Oil—
20Y Treasury—
US Dollar—
VIX—
Emerging Mkts—
Intl Developed—
Bitcoin—
S&P 500—
NASDAQ 100—
Dow Jones—
Russell 2000—
Gold—
Crude Oil—
20Y Treasury—
US Dollar—
VIX—
Emerging Mkts—
Intl Developed—
Bitcoin—

Industry Knowledge That Drives Better Outcomes

Effective investment banking requires more than transactional skill — it demands genuine fluency in the industries where our clients operate. Eastgate Securities has built deep sector expertise across twelve core verticals, enabling our bankers to speak the language of each industry, anticipate regulatory and market dynamics, and connect clients with investors who understand their business.

This sector depth translates directly into better execution: more targeted investor outreach, more credible positioning, and stronger outcomes at every stage of the capital raising or advisory process.

Coverage Areas

Twelve Core Verticals

Healthcare

Biopharmaceuticals, medical devices, diagnostics, and healthcare services.

We advise healthcare companies navigating the complex intersection of science, regulation, and capital markets. From early-stage biotech seeking growth capital to established medical device companies pursuing strategic transactions, our team brings deep familiarity with FDA pathways, reimbursement dynamics, and the institutional investor community that drives healthcare valuations.

  • Biopharmaceutical capital raises
  • Medical device and diagnostics
  • Healthcare services M&A
  • FDA-stage company advisory
  • Life sciences IPO preparation

Technology

Software, fintech, cybersecurity, and emerging technology platforms.

Technology companies require capital partners who understand rapid growth cycles, recurring revenue models, and the competitive dynamics of platform businesses. We advise software, fintech, and emerging technology companies on capital raises, strategic acquisitions, and public market transitions — with a focus on positioning that resonates with institutional technology investors.

  • SaaS and software capital raises
  • Fintech and payments advisory
  • Cybersecurity sector transactions
  • Technology M&A and divestitures
  • Up-listings and exchange transitions

Artificial Intelligence

AI platforms, machine learning infrastructure, and applied AI companies.

Artificial intelligence is redefining competitive advantage across every industry. We advise AI-native companies and enterprises deploying AI at scale — from foundational model developers and MLOps infrastructure providers to applied AI companies in healthcare, finance, and logistics. Our team understands the unique valuation dynamics, IP considerations, and investor appetite that define this rapidly evolving sector.

  • AI platform and infrastructure raises
  • Applied AI company advisory
  • Machine learning and MLOps
  • AI-driven SaaS transactions
  • Strategic partnerships and M&A

Agriculture

AgTech, crop sciences, food production, and agricultural infrastructure.

Agriculture is undergoing a fundamental transformation driven by technology, sustainability imperatives, and global food security demands. We work with AgTech innovators, crop science companies, and agricultural infrastructure businesses to access growth capital and execute strategic transactions in a sector that increasingly attracts institutional attention.

  • AgTech and precision agriculture
  • Crop science and inputs
  • Agricultural infrastructure
  • Food production and processing
  • Sustainability-linked financings

Aviation

Airlines, MRO, aerospace components, and aviation services.

Aviation is a capital-intensive sector where relationships, regulatory knowledge, and timing are critical. Our team advises airlines, MRO providers, aerospace component manufacturers, and aviation services companies on debt and equity financings, sale-leaseback structures, and strategic transactions — with an understanding of the cyclical and structural forces that shape aviation valuations.

  • Airline and fleet financing
  • MRO and aftermarket services
  • Aerospace component manufacturers
  • Sale-leaseback structures
  • Aviation services M&A

Energy

Oil & gas, renewables, power generation, and energy transition.

Energy markets are being reshaped by the transition to cleaner sources, evolving commodity cycles, and shifting regulatory frameworks. We advise both traditional energy companies and clean energy developers on capital raises, project financings, and strategic transactions — bringing sector fluency to an industry where execution timing and investor relationships are decisive.

  • Oil & gas capital raises
  • Renewable energy project finance
  • Power generation and utilities
  • Energy transition advisory
  • Midstream and infrastructure

Mining

Precious metals, base metals, critical minerals, and mining services.

Mining companies face unique capital markets challenges — from resource definition and permitting timelines to commodity price exposure and ESG scrutiny. Eastgate has extensive experience advising junior and mid-tier mining companies on equity financings, royalty structures, and strategic transactions, with strong relationships among the specialist mining investor community.

  • Junior and mid-tier mining financings
  • Precious and base metals
  • Critical minerals and battery materials
  • Royalty and streaming structures
  • Mining M&A and asset transactions

Real Estate

REITs, real estate operating companies, and property development.

Real estate capital markets require a nuanced understanding of asset classes, cap rate dynamics, and the distinct investor bases that drive REIT and operating company valuations. We advise real estate companies on equity offerings, debt financings, and strategic transactions — with experience across commercial, residential, industrial, and specialty property sectors.

  • REIT equity and debt offerings
  • Real estate operating companies
  • Commercial and industrial property
  • Development company financings
  • Real estate M&A advisory

Consumer Packaged Goods

Branded consumer products, food & beverage, and retail distribution.

Consumer brands require capital partners who understand brand equity, retail distribution dynamics, and the path from emerging brand to scaled platform. We advise CPG companies on growth equity raises, strategic acquisitions, and exit transactions — connecting consumer-focused management teams with the institutional and strategic investors who drive value in the sector.

  • Branded consumer product raises
  • Food & beverage transactions
  • Retail and e-commerce distribution
  • Consumer M&A and brand acquisitions
  • Growth equity and private placement

Telecommunications

Wireless carriers, broadband infrastructure, and communications technology.

Telecommunications companies operate at the intersection of infrastructure, regulation, and rapid technological change. We advise wireless carriers, broadband providers, tower companies, and communications technology firms on capital raises, spectrum transactions, and strategic M&A — with an understanding of the regulatory environment and infrastructure economics that define sector valuations.

  • Wireless and broadband capital raises
  • Tower and infrastructure transactions
  • Spectrum and licensing advisory
  • Telecom M&A and consolidation
  • Communications technology financings

Biotechnology

Drug development, genomics, cell & gene therapy, and biotech platforms.

Biotechnology companies face a distinctive capital markets journey — from pre-clinical financing through clinical milestones to commercialization. Our team advises biotech companies at every stage, with deep knowledge of clinical-stage valuation, FDA regulatory pathways, licensing and partnership structures, and the specialist investor base that drives biotech capital formation.

  • Clinical-stage biotech financings
  • Genomics and precision medicine
  • Cell and gene therapy advisory
  • Licensing and partnership transactions
  • Biotech IPO and follow-on offerings

Defense & Aerospace

Defense contractors, space technology, and dual-use platforms.

Defense and aerospace companies require capital partners with an appreciation for long procurement cycles, government contract dynamics, and the growing convergence of commercial and defense technology. We advise defense contractors, space technology companies, and dual-use platform businesses on equity financings, strategic partnerships, and M&A — with a focus on the investor community that understands this sector's unique risk and return profile.

  • Defense contractor financings
  • Space technology and launch advisory
  • Dual-use technology transactions
  • Government contract company M&A
  • Defense technology partnerships

Deep Expertise. Focused Execution.

Our sector specialists are available to discuss your industry's specific capital markets dynamics and how Eastgate can help you achieve your strategic objectives.